{"id":45540,"date":"2024-11-19T18:17:52","date_gmt":"2024-11-19T12:47:52","guid":{"rendered":"https:\/\/theindianinfluencer.com\/index.php\/2024\/11\/19\/medicamen-organics-reports-49-percent-total-revenue-increase-in-h1-fy25\/"},"modified":"2024-11-19T18:17:52","modified_gmt":"2024-11-19T12:47:52","slug":"medicamen-organics-reports-49-percent-total-revenue-increase-in-h1-fy25","status":"publish","type":"post","link":"https:\/\/theindianinfluencer.com\/index.php\/2024\/11\/19\/medicamen-organics-reports-49-percent-total-revenue-increase-in-h1-fy25\/","title":{"rendered":"Medicamen Organics Reports 49 Percent Total Revenue Increase In H1 FY25"},"content":{"rendered":"<div>\n<div>\n<p><strong>New Delhi [India], November 19: <\/strong>Medicamen Organics Limited (MOL) (NSE- MEDIORG) one of the prominent players in the pharmaceutical sector specializing in the development, manufacturing, and distribution of an extensive range of pharmaceutical dosages has announced its Unaudited H1 FY25 results<\/p>\n<p><strong>Key Financial Highlights<\/strong><\/p>\n<p>H1 FY25<\/p>\n<p>\u2022\u2002Total Revenue of\u00a0\u20b9\u00a01,685.66\u00a0Lakhs, YoY growth of 48.91%<\/p>\n<p>\u2022\u2002EBITDA of\u00a0\u20b9\u00a0277.44\u00a0Lakhs, YoY growth of 15.39%<\/p>\n<p>\u2022\u2002Net Profit of\u00a0\u20b9\u00a0151.07\u00a0Lakhs, YoY growth of 10.88%<\/p>\n<p>Commenting on the Financial Performance, Mr. Bal Kishan Gupta, Managing Director, said,\u201d We are pleased to report significant growth in total income, EBITDA, and net profit for the first half of FY25. This reflects the increasing demand for our organic health solutions and the effectiveness of our operational strategies. Our net profit continues to show positive growth, reinforcing the strength of our business.<\/p>\n<p>Looking ahead, we are confident in our future prospects. Our agility allows us to secure key partnerships with global healthcare leaders, while our robust product pipeline promises the development of more &amp; more products as per market requirements. With low debt, strong financials, and an expanding global presence, we are poised for substantial growth. We are well-positioned to expand and grow in the export sector through our own brands, and we are committed to creating lasting value for our investors.\u201d<\/p>\n<p><strong>Key Operational Highlights\u00a0<\/strong><\/p>\n<table>\n<tbody>\n<tr>\n<td>Expanding Global Reach<\/td>\n<td>The Company\u00a0has signed an MoU with Depot Pharmacy Yego Limited in Rwanda,\u00a0enhancing\u00a0its overseas presence and expanding access to quality healthcare products in East Africa.<\/td>\n<\/tr>\n<tr>\n<td>Strategic Partnership to Expand in French West Africa<\/td>\n<td>Signed a Memorandum of Understanding with Mr Vaibhav Kashinath Chaudhari and Mistycube Analytics to form Grande Etoile Pharmaceuticals Ltd.<\/p>\n<p>\u2022\u00a0Objective:\u00a0Build a strong business in the FWA market through\u00a0strong\u00a0marketing.<\/p>\n<p>\u2022\u00a0Ownership:\u00a0MOL will hold a 51% stake in GEPL.<\/p>\n<p>\u2022\u00a0Investment:\u00a0Authorized capital of\u00a0\u20b95 crores.<\/p>\n<p>\u2022\u00a0Operations:\u00a0GEPL will register products in\u00a0FWA (own brands).<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><em> If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.<\/em><\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>New Delhi [India], November 19: Medicamen Organics Limited (MOL) (NSE- MEDIORG) one of the prominent players in the pharmaceutical sector specializing in the development, manufacturing, and distribution of an extensive range of pharmaceutical dosages has announced its Unaudited H1 FY25 results Key Financial Highlights H1 FY25 \u2022\u2002Total Revenue of\u00a0\u20b9\u00a01,685.66\u00a0Lakhs, YoY growth of 48.91% \u2022\u2002EBITDA of\u00a0\u20b9\u00a0277.44\u00a0Lakhs, [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":45541,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[20],"class_list":["post-45540","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","tag-business"],"_links":{"self":[{"href":"https:\/\/theindianinfluencer.com\/index.php\/wp-json\/wp\/v2\/posts\/45540","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/theindianinfluencer.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/theindianinfluencer.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/theindianinfluencer.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/theindianinfluencer.com\/index.php\/wp-json\/wp\/v2\/comments?post=45540"}],"version-history":[{"count":0,"href":"https:\/\/theindianinfluencer.com\/index.php\/wp-json\/wp\/v2\/posts\/45540\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/theindianinfluencer.com\/index.php\/wp-json\/wp\/v2\/media\/45541"}],"wp:attachment":[{"href":"https:\/\/theindianinfluencer.com\/index.php\/wp-json\/wp\/v2\/media?parent=45540"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/theindianinfluencer.com\/index.php\/wp-json\/wp\/v2\/categories?post=45540"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/theindianinfluencer.com\/index.php\/wp-json\/wp\/v2\/tags?post=45540"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}